Tiziana Life Sciences Ltd (TLSA)
NASDAQ: TLSA · Real-Time Price · USD
2.130
-0.095 (-4.27%)
At close: Aug 13, 2025, 4:00 PM
2.210
+0.080 (3.76%)
After-hours: Aug 13, 2025, 7:58 PM EDT
Tiziana Life Sciences Employees
Tiziana Life Sciences had 9 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
9
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,318,111
Market Cap
237.42M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
TLSA News
- 2 days ago - FDA Approves Tiziana Life Sciences Phase 2 IND for Multiple System Atrophy - GlobeNewsWire
- 23 days ago - Tiziana Life Sciences Announces Immunologic Analysis of Nasal Foralumab in Moderate Alzheimer's Patient - GlobeNewsWire
- 2 months ago - Tiziana: Scope Of Foralumab Goes Beyond That Of Multiple Sclerosis Targeting - Seeking Alpha
- 2 months ago - Tiziana Life Sciences Expands Phase 2 Clinical Trial of Intranasal Foralumab with Commencement of First Patient Dosing at Weill Cornell Multiple Sclerosis Center - GlobeNewsWire
- 2 months ago - Tiziana Life Sciences to Present at the Bio International Convention - GlobeNewsWire
- 2 months ago - Tiziana Life Sciences Announces Interview Highlighting Intranasal Foralumab for the Treatment of Moderate Alzheimer's Disease - GlobeNewsWire
- 3 months ago - Journal of Clinical Nuclear Medicine Publishes Results of Tiziana's Nasal Foralumab in Study Treating Moderate Alzheimer's Disease - GlobeNewsWire
- 3 months ago - Tiziana Life Sciences Announces Purchase of Shares by Chairman - GlobeNewsWire